Abstract | PURPOSE: MATERIALS AND METHODS: Of the patients who were diagnosed with TAO from March 2008 to March 2012, we performed a retrospective chart review on those who had undergone total thyroidectomy for thyroid cancer or a benign mass of the thyroid before the occurrence of ophthalmopathy. RESULTS: Of the 206 patients diagnosed with TAO, seven (3.4%) met the inclusion criteria. The mean age of the subjects was 47.4 years, and all were female. Six patients were diagnosed with papillary thyroid cancer, and one was diagnosed with a benign mass. The duration between total thyroidectomy and onset of TAO ranged from 3-120 months (median 48 months). Ophthalmic manifestations varied among cases. Except for the patient who was diagnosed with a benign mass, all patients showed hyperthyroid status and were under Synthroid hormone treatment at the time of TAO development. Five of these six patients had positive levels of thyroid-stimulating hormone ( TSH) receptor autoantibodies. CONCLUSION:
|
Authors | Sun Young Jang, Ka Hyun Lee, Jong Rok Oh, Bo Yeon Kim, Jin Sook Yoon |
Journal | Yonsei medical journal
(Yonsei Med J)
Vol. 56
Issue 5
Pg. 1389-94
(Sep 2015)
ISSN: 1976-2437 [Electronic] Korea (South) |
PMID | 26256985
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- Receptors, Thyrotropin
- Thyrotropin
|
Topics |
- Adult
- Aged
- Autoantibodies
(blood)
- Carcinoma
- Carcinoma, Papillary
(immunology, surgery)
- Female
- Graves Ophthalmopathy
(diagnosis, immunology)
- Humans
- Male
- Middle Aged
- Postoperative Complications
(etiology, immunology, pathology)
- Receptors, Thyrotropin
- Retrospective Studies
- Thyroid Cancer, Papillary
- Thyroid Neoplasms
(complications, surgery)
- Thyroidectomy
(adverse effects, methods)
- Thyrotropin
(blood)
- Treatment Outcome
|